NBTX-001

N/A

Report date: 2024/11/20 20:00:31
NME

Base Information

Drug NameNBTX-001
Drug Alias NameNBTX-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMclean Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNobilis Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsStress Disorders, Post-TraumaticParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A